• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Best of Respiratory Coverage in 2022

Slideshow

Take a look back at our most popular respiratory coverage for 2022.

Related Videos
Related Content
2022-2023 Influenza Season Classified as High Severity by CDC

2022-2023 Influenza Season Classified as High Severity by CDC

November 29th 2023
Article

This season marks the fourth to be classified as high severity since the 2009 influenza A(H1N1) pandemic.

pharmacist holds prescription packet

Good Neighbor Pharmacy Customers Across the US Reflect and Look Forward

September 20th 2021
Podcast

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

COVID-19 Hospital Admissions Could be More Accurately Predicted With Wastewater Data

COVID-19 Hospital Admissions Could be More Accurately Predicted With Wastewater Data

November 27th 2023
Article

A new study found that models that included wastewater data were 15% more accurate when compared to models that only included clinical case data.

Over the Counter

McKesson Series: Using Technology to Simplify Vaccination Programs

December 22nd 2020
Podcast

Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others.

Flu Vaccine May Protect Against Heart Attack, Cardiovascular Events

Flu Vaccine May Protect Against Heart Attack, Cardiovascular Events

November 24th 2023
Article

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

FDA, CDC Increase Availability of RSV Monoclonal Antibody for Infants

FDA, CDC Increase Availability of RSV Monoclonal Antibody for Infants

November 23rd 2023
Article

The federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.

© 2023 MJH Life Sciences

All rights reserved.